Lack of nitric oxide mediation of flow-dependent arteriolar dilation in type I diabetes is restored by sepiapterin

Journal of Vascular Research

Volumn 40, Issue 1, 2003, Pages 47-57

  Bagi, Zsolt ^a,b   Koller, Akos ^a,b  

^a SEMMELWEIS UNIVERSITY   (Hungary)

^b NEW YORK MEDICAL COLLEGE   (United States)

Author keywords

Arteriole; Diabetes mellitus type I; Flow induced dilation; Nitric oxide; Tetrahydrobiopterin

Indexed keywords

2,4 DIAMINO 6 HYDROXYPYRIMIDINE; ACETYLCHOLINE; CATALASE; GLUCOSE; INDOMETACIN; N(G) NITROARGININE METHYL ESTER; NITRIC OXIDE; NITROPRUSSIDE SODIUM; PROSTAGLANDIN; PYRIMIDINE DERIVATIVE; PYROGALLOL; SEPIAPTERIN; SUPEROXIDE DISMUTASE; TETRAHYDROBIOPTERIN; UNCLASSIFIED DRUG;

ANIMAL MODEL; ANIMAL TISSUE; ARTERIOLE; ARTERY BLOOD FLOW; ARTERY DIAMETER; ARTERY DILATATION; ARTICLE; BIOAVAILABILITY; CONTROLLED STUDY; DISEASE EXACERBATION; DRUG EFFECT; GLUCOSE BLOOD LEVEL; GRACILIS MUSCLE; INSULIN DEPENDENT DIABETES MELLITUS; MALE; MICROANGIOPATHY; NONHUMAN; PRIORITY JOURNAL; RAT; STREPTOZOCIN DIABETES; SYNTHESIS;

ACETYLCHOLINE; ANIMALS; ARTERIOLES; BIOPTERIN; BLOOD FLOW VELOCITY; CATALASE; DIABETES MELLITUS, EXPERIMENTAL; DIABETES MELLITUS, TYPE 1; ENZYME INHIBITORS; HYPOXANTHINES; MALE; MUSCLE, SMOOTH, VASCULAR; NG-NITROARGININE METHYL ESTER; NITRIC OXIDE; NITRIC OXIDE DONORS; NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE TYPE III; NITROPRUSSIDE; PTERIDINES; PTERINS; PYROGALLOL; RATS; RATS, WISTAR; REACTIVE OXYGEN SPECIES; SUPEROXIDES; VASODILATION;

EID: 0037228474     PISSN: 10181172     EISSN: None     Source Type: Journal    
DOI: 10.1159/000068938     Document Type: Article

References (58)

1. Sowers JR, Epstein M, Frohlich ED: Diabetes, hypertension, and cardiovascular disease: An update. Hypertension 2001;37:1053-1059.
2. Kannel WB, McGee DL: Diabetes and cardiovascular disease: The Framingham Study. JAMA 1979;241:2035-2038.
3. Ruderman NB, Gupta S, Sussman I: An overview; in Ruderman NB, Williamson JR, Brownlee ML (eds): Hyperglycemia, Diabetes, and Vascular Disease. New York, Oxford University Press, 1992, pp 3-20.
4. Stehouwer CDA, Lambert J, Donker AJM, Hinsberg VWM: Endothelial dysfunction and pathogenesis of diabetic angiopathy. Cardiovasc Res 1997;34:55-98.
5. De Vriese AS, Verbeuren TJ, Voorde JV, Lameire NH, Vanhoutte PM: Endothelial dysfunction in diabetes. Br J Pharmacol 2000;130:963-974.
6. Pieper GM: Review of alterations in endothelial nitric oxide production in diabetes. Protective role of arginine on endothelial dysfunction. Hypertension 1998;31:1047-1060.
7. Katusic ZS: Vascular endothelial dysfunction: Does tetrahydrobiopterin play a role? Am J Physiol Heart Circ Physiol 2001;281:H981-H986.
8. Hink U, Li H, Mollnau H, Oelze M, Matheis E, Hartmann M, Skatchkov M, Thaiss F, Stahl RAK, Warnholtz A, Meinerz T, Griendling K, Harrison DG, Forstermann U, Munzer T: Mechanisms underlying endothelial dysfunction in diabetes mellitus. Circ Res 2001;88:E14-E22.
9. Zenere BM, Arcaro G, Saggiani F, Rossi L, Muggeo M, Lechi A: Noninvasive detection of functional alterations of the arterial wall in IDDM patients with and without microalbuminuria. Diabetes Care 1995;18:975-982.
10. Gazis A, White DJ, Page SR, Cockcroft JR: Effect of oral vitamin E (alpha-tocopherol) supplementation on vascular endothelial function in type 2 diabetes mellitus. Diabet Med 1999;16:304-311.
11. Enderle MD, Benda N, Schmuelling RM, Haering HU, Pfohl M: Preserved endothelial function in IDDM patients, but not in NIDDM patients compared with healthy subjects. Diabetes Care 1998;21:271-277.
12. Smits P, Kapma J, Jacobs M, Lutterman J, Thien T: Endothelium-dependent vascular relaxation in patients with type I diabetes. Diabetes 1993;42:148-153.
13. Lambert J, Aarsen M, Donker AJ, Stehouwer CD: Endothelium-dependent and -independent vasodilation of large arteries in normalbuminuric insulin-dependent diabetes mellitus. Arterioscler Thromb Vasc Biol 1996;16:705-711.
14. Hill MA, Meininger GA, Granger HJ: Altered skeletal muscle hemodynamics after one week of streptozotocin-induced diabetes. Microcirc Endothelium Lymphatics 1985;2:687-704.
15. Tooke JE: Microvascular function in human diabetes. Diabetes 1995;44:721-726.
16. Lash JM, Bohlen HG: Structural and functional origins of suppressed acetylcholine vasodilation in diabetic rat intestinal arterioles. Circ Res 1991;69:1259-1268.
17. Diederich D, Skopec J, Diederich A, Dai FX: Endothelial dysfunction in mesenteric resistance arteries of diabetic rats: Role of free radicals. Am J Physiol 1994;266:H1153-H1161.
18. Heygate KM, Lawrence IG, Bennett MA, Thurston H: Impaired endothelium-dependent relaxation in isolated resistance arteries of spontaneously diabetic rats. Br J Pharmacol 1995;116:3251-3259.
19. 2+ channels and protein kinase C. Cardiovasc Res 1999;43:1018-1028.
20. Bolz SS, de Wit C, Pohl U: Endothelium-derived hyperpolarizing factor but not NO reduces smooth muscle Ca2+ during acetylcholine-induced dilation of microvessels. Br J Pharmacol 1999;128:124-134.
21. Ca channels and elicit EDHF-type arteriolar dilation via gap junctions. Am J Physiol Heart Circ Physiol 2002;282:H1760-H1767.
22. Kuo L, Davis MJ, Chilian WM: Endothelium-dependent, flow-induced dilation of isolated coronary arterioles. Am J Physiol 1990;259:H1063-H1070.
23. Koller A, Sun D, Huang A, Kaley G: Corelease of nitric oxide and prostaglandins mediates flow-dependent dilation of rat gracilis muscle arterioles. Am J Physiol 1994;267:H326-H332.
24. Fujii K, Heistad DD, Faraci FM: Effect of diabetes mellitus on flow-mediated and endothelium-dependent dilation of the rat basilar artery. Stroke 1992;23:1494-1498.
25. Tribe RM, Thomas CR, Poston L: Flow-induced dilation in isolated resistance arteries from control and streptozotocin-diabetic rats. Diabetologia 1998;41:34-39.
26. Giugliano D, Ceriello A, Paolisso G: Oxidative stress and diabetic vascular complications. Diabetes Care 1996;19:257-267.
27. Hattori Y, Kawasaki H, Abe K, Kanno M: Superoxide dismutase recovers altered endothelium-dependent relaxation in diabetic rat aorta. Am J Physiol 1991;261:H1086-H1094.
28. Pieper GM, Siebeneich W, Roza AM, Jordan M, Adams MB: Chronic treatment in vivo with dimethylthiourea, a hydroxyl radical scavenger, prevents diabetes-induced endothelial dysfunction. J Cardiovasc Pharmacol 1996;28:741-745.
29. Ting HH, Timimi FK, Boles KS, Creager SJ, Ganz P, Creager MA: Vitamin C improves endothelium-dependent vasodilation in patients with non-insulin-dependent diabetes mellitus. J Clin Invest 1996;97:22-28.
30. Alderton WK, Cooper CE, Knowles RG: Nitric oxide synthases: Structure, function and inhibition. Biochem J 2001;357:593-615.
31. Thony B, Auerbach G, Blau N: Tetrahydrobiopterin biosynthesis, regeneration and functions. Biochem J 2000;347:1-16.
32. Tiefenbacher CP: Tetrahydrobiopterin: A critical cofactor for eNOS and a strategy in the treatment of endothelial dysfunction? Am J Physiol Heart Circ Physiol 2001;280:H2484-H2488.
33. Kinoshita H, Milstien S, Wambi C, Katusic ZS: Inhibition of tetrahydrobiopterin biosynthesis impairs endothelium-dependent relaxations in canine basilar artery. Am J Physiol 1997;273:H718-H724.
34. Pieper GM: Acute amelioration of diabetic endothelial dysfunction with a derivative of the nitric oxide synthase cofactor, tetrahydrobiopterin. J Cardiovasc Pharmacol 1997;29:8-15.
35. Shinozaki K, Nishio Y, Okamura T, Yoshida Y, Maegawa H, Kojima H, Masada M, Toda N, Kikkawa R, Kashiwagi A: Oral administration of tetrahydrobiopterin prevents endothelial dysfunction and vascular oxidative stress in the aortas of insulin-resistant rats. Circ Res 2000;87:566-573.
36. Heitzer T, Krohn K, Albers S, Meinertz T: Tetrahydrobiopterin improves endothelium-dependent vasodilation by increasing nitric oxide activity in patients with type II diabetes mellitus. Diabetologia 2000;43:1435-1438.
37. Meininger CJ, Marinos RS, Hatakeyama K, Martinez-Zaguilan R, Rojas JD, Kelly KA, Wu G: Impaired nitric oxide production in coronary endothelial cells of the spontaneously diabetic BB rat is due to tetrahydrobiopterin deficiency. Biochem J 2000;349:353-356.
38. Huang A, Sun D, Kaley G, Koller A: Superoxide release to high intra-arteriolar pressure reduces nitric oxide-mediated shear stress- and agonist-induced dilations. Circ Res 1998;83:960-965.
39. Ungvari Z, Csiszar A, Bagi Z, Koller A: Impaired nitric oxide-mediated flow-induced coronary dilation in hyperhomocysteinemia: Morphological and functional evidence for increased peroxynitrite formation. Am J Pathol 2002;161:145-153.
40. Tsutsui M, Milstien S, Katusic ZS: Effect of tetrahydrobiopterin on endothelial function in canine middle cerebral arteries. Circ Res 1996;79:336-342.
41. Tiefenbacher CP, Bleeke T, Vahl C, Amman K, Vogt A, Kubler W: Endothelial dysfunction of coronary arteries is improved by tetrahydrobiopterin in atherosclerosis. Circulation 2000;102:2172-2179.
42. Nichol CA, Lee CL, Edelstein MP, Chao JY, Duch DS: Biosynthesis of tetrahydrobiopterin by de novo and salvage pathways in adrenal medulla extracts, mammalian cell cultures, and rat brain in vivo. Proc Natl Acad Sci USA 1983;80:1546-1550.
43. Werner-Felmayer G, Gross SS: Analysis of tetrahydrobiopterin and its role in nitric oxide synthesis; in Feelisch M, Stamler JS (eds): Methods in Nitric Oxide Research. New York, Wiley, 1996, pp 271-299.
44. Tóth M, Kukor Z, Sahin-Tóth M: Differential response of basal and tetrahydrobiopterin-stimulated activities of placental type III nitric oxide synthase to sodium dodecyl sulphate: Relation to dimeric structure. Mol Hum Reprod 1998;4:1165-1172.
45. Marklund S, Marklund G: Involvement of the superoxide anion radical in the autooxidation of pyrogallol and a convenient assay for superoxide dismutase. Eur J Biochem 1974;47:469-474.
46. Ignarro LJ, Byrns RE, Buga GM, Wood KS, Chaudhuri G: Pharmacological evidence that endothelium-derived relaxing factor is nitric oxide: Use of pyrogallol and superoxide dismutase to study endothelium-dependent and nitric oxide-elicited vascular smooth muscle relaxation. J Pharmacol Exp Ther 1988;244:181-189.
47. Wolff SP, Dean RT: Glucose autoxidation and protein modification. The potential role of 'autoxidative glycosylation' in diabetes. Biochem J 1987;245:243-250.
48. Yan SD, Schmidt AM, Anderson GM, Zhang J, Brett J, Zou YS, Pinsky D, Stern DJ: Enhanced cellular oxidant stress by the interaction of advanced glycation end products with their receptors/binding proteins. Biol Chem 1994;269:9889-9897.
49. Taylor PD, Poston L: The effect of hyperglycaemia on function of rat isolated mesenteric resistance artery. Br J Pharmacol 1994;113:801-808.
50. Hamon CG, Cutler P, Blair JA: Tetrahydrobiopterin metabolism in the streptozotocin induced diabetic state in rats. Clin Chim Acta 1989;181:249-253.
51. Kinoshita H, Katusic ZS: Exogenous tetrahydrobiopterin causes endothelium-dependent contractions in isolated canine basilar artery. Am J Physiol 1996;271:H738-H743.
52. Tajima M, Sakagami H: Tetrahydrobiopterin impairs the action of endothelial nitric oxide via superoxide derived from platelets. Br J Pharmacol 2000;131:958-964.
53. Vasquez-Vivar J, Kalyanaraman B, Martasek P, Hogg N, Masters BS, Karoui H, Tordo P, Pritchard KA Jr: Superoxide generation by endothelial nitric oxide synthase: The influence of cofactors. Proc Natl Acad Sci USA 1998;95:9220-9225.
54. Wever RMF, van Dam T, van Rijn HJ, de Groot F, Rabelink TJ: Tetrahydrobiopterin regulates superoxide and nitric oxide generation by recombinant endothelial nitric oxide synthase. Biochem Biophys Res Commun 1997;237:340-344.
55. Xia Y, Zweier JL: Direct measurement of nitric oxide generation from nitric oxide synthase. Proc Natl Acad Sci USA 1997;94:12705-12710.
56. Pou S, Keaton L, Surichamorn W, Rosen GM: Mechanism of superoxide generation by neuronal nitric-oxide synthase. J Biol Chem 1999;274:9573-9580.
57. Verma S, Arikawa E, Yao L, Laher I, McNeill JH: Insulin-induced vasodilation is dependent on tetradydrobiopterin synthesis. Metabolism 1998;47:1037-1039.
58. Ishii M, Shimizu S, Kiuchi Y, Nagai T, Yamamoto T: Insulin stimulates tetrahydrobiopterin synthesis in mouse brain microvascular endothelial cells. Pteridines 1999;10:213-216.